Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HMG therapy for unexplained male infertility
IRCT20150317021497N5Phase 2Completed
- Sponsor
- Rafsanjan University of Medical Sciences
- Start
- Jan 2019
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human menopausal gonadotrophin in male infertility, sponsored by Rafsanjan University of Medical Sciences. Primary endpoint: Fertility. Started Jan 2019; status: completed.
02
Drugs
human menopausal gonadotrophin
03
Conditions
male infertility
Beyond the preview
Go deeper on IRCT20150317021497N5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20150317021497N5.